title: Olanzapine-induced oculogyric crisis.
authors.forename: Marcus C
authors.initials: MC
authors.lastname: Rosenhagen
authors.forename: Ulrike
authors.initials: U
authors.lastname: Schmidt
authors.forename: Juliane
authors.initials: J
authors.lastname: Winkelmann
authors.forename: Martin
authors.initials: M
authors.lastname: Ebinger
authors.forename: Iris
authors.initials: I
authors.lastname: Knetsch
authors.forename: Frank
authors.initials: F
authors.lastname: Weber
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D015835:Ocular Motility Disorders / Q000139:chemically induced* / Q000188:drug therapy; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D008094:Lithium; D000077152:Olanzapine